, , ,
doi.org/10.1093/humrep/13.3.573, hdl.handle.net/1765/65052
Human Reproduction
Department of Gynaecology & Obstetrics

de Jong, D., Macklon, N., Mannaerts, B. M., Coelingh-Bennink, H. J. T., & Fauser, B. (1998). High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization. Human Reproduction, 13(3), 573–575. doi:10.1093/humrep/13.3.573